Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 132

1.

Methamphetamine-related psychiatric symptoms and reduced brain dopamine transporters studied with PET.

Sekine Y, Iyo M, Ouchi Y, Matsunaga T, Tsukada H, Okada H, Yoshikawa E, Futatsubashi M, Takei N, Mori N.

Am J Psychiatry. 2001 Aug;158(8):1206-14.

PMID:
11481152
2.

Association of dopamine transporter loss in the orbitofrontal and dorsolateral prefrontal cortices with methamphetamine-related psychiatric symptoms.

Sekine Y, Minabe Y, Ouchi Y, Takei N, Iyo M, Nakamura K, Suzuki K, Tsukada H, Okada H, Yoshikawa E, Futatsubashi M, Mori N.

Am J Psychiatry. 2003 Sep;160(9):1699-701.

PMID:
12944350
3.

Association of dopamine transporter reduction with psychomotor impairment in methamphetamine abusers.

Volkow ND, Chang L, Wang GJ, Fowler JS, Leonido-Yee M, Franceschi D, Sedler MJ, Gatley SJ, Hitzemann R, Ding YS, Logan J, Wong C, Miller EN.

Am J Psychiatry. 2001 Mar;158(3):377-82.

PMID:
11229977
4.
5.

Altropane, a SPECT or PET imaging probe for dopamine neurons: III. Human dopamine transporter in postmortem normal and Parkinson's diseased brain.

Madras BK, Gracz LM, Fahey MA, Elmaleh D, Meltzer PC, Liang AY, Stopa EG, Babich J, Fischman AJ.

Synapse. 1998 Jun;29(2):116-27.

PMID:
9593102
6.
7.
8.

Altropane, a SPECT or PET imaging probe for dopamine neurons: II. Distribution to dopamine-rich regions of primate brain.

Madras BK, Gracz LM, Meltzer PC, Liang AY, Elmaleh DR, Kaufman MJ, Fischman AJ.

Synapse. 1998 Jun;29(2):105-15.

PMID:
9593101
9.

Striatal dopamine transporter binding in neuroleptic-naive patients with schizophrenia studied with positron emission tomography.

Laakso A, Vilkman H, Alakare B, Haaparanta M, Bergman J, Solin O, Peurasaari J, Räkköläinen V, Syvälahti E, Hietala J.

Am J Psychiatry. 2000 Feb;157(2):269-71.

PMID:
10671399
10.

Neuromechanism of developing methamphetamine psychosis: a neuroimaging study.

Iyo M, Sekine Y, Mori N.

Ann N Y Acad Sci. 2004 Oct;1025:288-95.

PMID:
15542729
11.

Striatal dopamine nerve terminal markers in human, chronic methamphetamine users.

Wilson JM, Kalasinsky KS, Levey AI, Bergeron C, Reiber G, Anthony RM, Schmunk GA, Shannak K, Haycock JW, Kish SJ.

Nat Med. 1996 Jun;2(6):699-703.

PMID:
8640565
12.

Changes in dopamine availability in the nigrostriatal and mesocortical dopaminergic systems by gait in Parkinson's disease.

Ouchi Y, Kanno T, Okada H, Yoshikawa E, Futatsubashi M, Nobezawa S, Torizuka T, Tanaka K.

Brain. 2001 Apr;124(Pt 4):784-92.

PMID:
11287377
13.

Dopamine transporters are markedly reduced in Lesch-Nyhan disease in vivo.

Wong DF, Harris JC, Naidu S, Yokoi F, Marenco S, Dannals RF, Ravert HT, Yaster M, Evans A, Rousset O, Bryan RN, Gjedde A, Kuhar MJ, Breese GR.

Proc Natl Acad Sci U S A. 1996 May 28;93(11):5539-43.

14.

Reproducibility and effect of levodopa on dopamine transporter function measurements: a [18F]CFT PET study.

Nurmi E, Bergman J, Eskola O, Solin O, Hinkka SM, Sonninen P, Rinne JO.

J Cereb Blood Flow Metab. 2000 Nov;20(11):1604-9.

PMID:
11083235
15.

SPECT imaging of the dopamine transporter with [(123)I]-beta-CIT reveals marked decline of nigrostriatal dopaminergic function in Parkinson's disease with urinary dysfunction.

Sakakibara R, Shinotoh H, Uchiyama T, Yoshiyama M, Hattori T, Yamanishi T.

J Neurol Sci. 2001 Jun 15;187(1-2):55-9.

PMID:
11440745
16.

Progression in Parkinson's disease: a positron emission tomography study with a dopamine transporter ligand [18F]CFT.

Nurmi E, Ruottinen HM, Kaasinen V, Bergman J, Haaparanta M, Solin O, Rinne JO.

Ann Neurol. 2000 Jun;47(6):804-8.

PMID:
10852547
17.

In vivo imaging of baboon and human dopamine transporters by positron emission tomography using [11C]WIN 35,428.

Wong DF, Yung B, Dannals RF, Shaya EK, Ravert HT, Chen CA, Chan B, Folio T, Scheffel U, Ricaurte GA, et al.

Synapse. 1993 Oct;15(2):130-42.

PMID:
8259524
18.

Rapid detection of Parkinson's disease by SPECT with altropane: a selective ligand for dopamine transporters.

Fischman AJ, Bonab AA, Babich JW, Palmer EP, Alpert NM, Elmaleh DR, Callahan RJ, Barrow SA, Graham W, Meltzer PC, Hanson RN, Madras BK.

Synapse. 1998 Jun;29(2):128-41.

PMID:
9593103
19.
20.

Iodine-123-IPT SPECT imaging of CNS dopamine transporters: nonlinear effects of normal aging on striatal uptake values.

Mozley PD, Kim HJ, Gur RC, Tatsch K, Muenz LR, McElgin WT, Kung MP, Mu M, Myers AM, Kung HF.

J Nucl Med. 1996 Dec;37(12):1965-70.

Supplemental Content

Support Center